[Syndrome "sickly child"]

Area of Science:

• Pediatrics
• Immunology
• Genetics

Background:

• The "sickly child" syndrome, characterized by frequent respiratory illnesses, poses a significant challenge in child healthcare.
• Recurrent respiratory tract infections are common in this vulnerable pediatric population.
• Understanding the underlying causes is crucial for effective management.

Purpose of the Study:

• To review the multifaceted causes of recurrent respiratory morbidity in "frequently ill children".
• To explore the role of genetic predisposition, immune dysregulation, and allergic components.
• To assess the impact of interventions like cycloferon on immune resistance.

Main Methods:

• Literature review of scientific studies on child respiratory health.
• Analysis of factors contributing to recurrent respiratory diseases, including genetic and immune markers.
• Examination of the influence of allergic conditions and neuroendocrine-immune interactions.
• Evaluation of therapeutic interventions targeting immune resistance.

Main Results:

• Genetic factors, including maternal health and blood groups, are linked to recurrent respiratory diseases.
• Immune imbalance, affecting cellular, humoral, and local immunity, contributes to chronic conditions.
• Allergic components significantly impact respiratory disease severity and are intertwined with neuroendocrine-immune pathways.
• Cycloferon administration reduced the frequency and duration of acute respiratory infections in "sickly children".

Conclusions:

• "Sickly child" syndrome is influenced by a complex interplay of genetic, immune, and allergic factors.
• Immune dysregulation is a key characteristic of children with recurrent respiratory infections.
• Cycloferon shows promise in improving immune resistance and reducing illness burden in this population.